Filana Therapeutics (FLNA) Change in Account Payables (2010 - 2022)

Filana Therapeutics' Change in Account Payables history runs 13 years deep, the most recent figure standing at $143000.0 for Q4 2022.

• In Q4 2022, Change in Account Payables fell 97.01% year-over-year to $143000.0; the TTM figure through Dec 2022 stood at -$3.4 million (down 155.49% YoY), while the FY2025 annual figure was $34.0 million, up 1264.54% from the prior year.
• Change in Account Payables for Q4 2022 stood at $143000.0, up from -$1.2 million in the prior quarter.
• The five-year high for Change in Account Payables was $4.8 million in Q4 2021, with the low at -$3.8 million in Q1 2022.
• The 5-year median for Change in Account Payables is $106000.0 (2019), against an average of $162650.0.
• The sharpest annual moves came in 2019 and 2022: Change in Account Payables jumped 6800.0% in 2019, then slumped 7972.34% in 2022.
• Filana Therapeutics' Change in Account Payables stood at -$255000.0 in 2018, then jumped by 144.31% to $113000.0 in 2019, then soared by 294.69% to $446000.0 in 2020, then soared by 971.97% to $4.8 million in 2021, then plunged by 97.01% to $143000.0 in 2022.
• Business Quant data shows FLNA's Change in Account Payables at $143000.0 in Q4 2022, -$1.2 million in Q3 2022, and $1.4 million in Q2 2022.